Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KMT5A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
AHCY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRRF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUSP28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR3654 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MRPL52 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIG3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506603 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PDZD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNAS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFIB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPAG5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNRNP25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on